Clinical Trials Directory

Trials / Unknown

UnknownNCT03706534

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

Breast Ultrasound Image Reviewed With Assistance of Deep Learning

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Samsung Medison · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

This study evaluates a second review of ultrasound images of breast lesions using an interactive "deep learning" (or artificial intelligence) program developed by Samsung Medical Imaging, to see if this artificial intelligence will help the Radiologist make more accurate diagnoses.

Detailed description

Using ultrasound images prospectively acquired, the purpose of this study entails a second review of ultrasound images with suspicious breast lesions using an interactive "deep learning" (or artificial intelligence) program developed by SamsungMedison Co.,Ltd. The images will be reviewed by the radiologists twice: first without, and then with assistance of artificial intelligence program by SamsungMedison Co., Ltd. BIRADS system will be used in this study. The objectives of the study are twofold: to quantify the statistical equivalence of radiologists' opinion and AI's output (CADe), and to check BIRADS score-based diagnostic accuracy (CADx) that is gained by the Radiologists' use of this interactive tool

Conditions

Interventions

TypeNameDescription
DEVICEUltrasound Image review with CADeThis software is a computer-aided detection (CADe) software application, designed to assist radiologist to analyze breast ultrasound images. S-Detect automatically segments and classifies shape, orientation, margin, lesion boundary, echo pattern, and posterior feature characteristics of user-selected region of interest. The device uses deep learning methods to perform tissue segmentation and classification of images.
DEVICEUltrasound Image review with CADxThis software is also a computer-assisted diagnostic(CADx) software application, designed to assist a medical doctor in determining diagnosis by presenting whether a lesion is malignant in a breast ultrasound image obtained from an ultrasound imaging device.
DEVICEUltrasound Image manual reviewThe images will be reviewed by the radiologists using BIRADS scheme without any assistance of artificial assistance. This review will be done off-line using a separate program in entirely manual mode. During this review, BIRADS descriptor choices by each radiologist and the time it takes for the radiologist to make such decision will be stored.
PROCEDUREBiopsySuspicious lesions found on breast ultrasound are then followed either by ultrasound guided biopsy or ultrasound imaging every 6 months for two years. For those who undergo biopsy, ultrasound provides images which are used to localize the lesion and guide the placement of the biopsy needle. The sample is sent to pathology for diagnosis, while the ultrasound guidance images are stored. For those who have imaging follow-up, ultrasound images of the breast mass are obtained, digitally stored and interpreted by the radiologist typically using BIRADS scheme.

Timeline

Start date
2018-09-20
Primary completion
2019-11-30
Completion
2020-01-31
First posted
2018-10-16
Last updated
2019-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03706534. Inclusion in this directory is not an endorsement.